Sk. Sullivan et al., IDENTIFICATION AND PARTIAL CHARACTERIZATION OF A DOMAIN IN CFTR THAT MAY BIND CYCLIC-NUCLEOTIDES DIRECTLY, Current biology, 5(10), 1995, pp. 1159-1167
Background: The cystic fibrosis transmembrane conductance regulator (C
FTR) is a-chloride channel that is activated by cAMP-dependent phospho
rylation. CFTR channel activity is also stimulated by cGMP-dependent p
rotein kinase and protein kinase C. Results: Here,we show that CFTR ch
annel activation by cGMP may also occur directly. In oocytes from one
third of Xenopus donors, the activation of CFTR by cGMP averaged 87 %
of the level achieved by cAMP. The currents activated by either cyclic
nucleotide displayed similar current-voltage relationships, kinetics,
pharmacology and halide selectivity. Sequential stimulation by cAMP a
nd cGMP was not additive, suggesting that both cyclic nucleotides acti
vate the same channel; cGMP was one order of magnitude more potent tha
n cAMP, and its action was insensitive to protein kinase inhibitors. A
nalysis of the amino-acid sequence of CFTR revealed a domain in the am
ino-terminal portion of the third cytoplasmic loop that resembles a cl
ass of cyclic-nucleotide-binding domains related to that of the catabo
lite-gene activator protein, CAP. Two CFTR residues in this domain - V
al397 and Lys420 - were identified which, when changed to alanine, alt
ered the response to cGMP independently of the response to cAMP. Concl
usions: We conclude that direct cyclic nucleotide binding may play a r
ole in channel gating of CFTR. The cGMP-binding domain may provide a u
seful target for pharmacologic intervention in cystic fibrosis.